Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2009) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 9.362 Q1 | 254 | 19 | 71 | 6531 | 1540 | 68 | 17.12 | 343.74 |  |
| 2 | Medicinal Research Reviews | journal | 3.062 Q1 | 150 | 27 | 85 | 5423 | 822 | 85 | 9.41 | 200.85 | |
| 3 | Pharmacology and Therapeutics | journal | 4.101 Q1 | 233 | 102 | 339 | 20033 | 3632 | 338 | 9.95 | 196.40 | |
| 4 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.487 Q1 | 82 | 12 | 39 | 2263 | 180 | 39 | 4.35 | 188.58 | |
| 5 | Food and Drug Law Journal | journal | 0.282 Q3 | 23 | 32 | 115 | 5476 | 47 | 115 | 0.44 | 171.13 | |
| 6 | Current Medicinal Chemistry | journal | 1.758 Q1 | 202 | 282 | 767 | 43990 | 4314 | 766 | 5.35 | 155.99 |  |
| 7 | Current Drug Metabolism | journal | 1.223 Q1 | 122 | 90 | 255 | 12668 | 1277 | 245 | 4.44 | 140.76 |  |
| 8 | Advances in Pharmacology | journal | 1.198 Q1 | 86 | 14 | 73 | 1944 | 220 | 68 | 3.81 | 138.86 | |
| 9 | Current Molecular Pharmacology | journal | 0.438 Q3 | 49 | 27 | 23 | 3594 | 29 | 23 | 1.26 | 133.11 | |
| 10 | Current Cancer Drug Targets | journal | 2.329 Q1 | 103 | 75 | 194 | 9712 | 1095 | 185 | 5.45 | 129.49 | |
| 11 | Annual Review of Pharmacology and Toxicology | journal | 11.689 Q1 | 224 | 19 | 64 | 2367 | 1528 | 64 | 24.74 | 124.58 | |
| 12 | Advances in Molecular Toxicology | book series | 0.166 Q3 | 18 | 8 | 14 | 942 | 10 | 12 | 0.88 | 117.75 | |
| 13 | Current Vascular Pharmacology | journal | 1.046 Q2 | 69 | 56 | 109 | 6582 | 355 | 102 | 3.15 | 117.54 | |
| 14 | Current Pharmaceutical Design | journal | 1.605 Q1 | 183 | 349 | 1097 | 40829 | 4830 | 980 | 4.56 | 116.99 | |
| 15 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 |  |
| 16 | Drug Resistance Updates | journal | 3.991 Q1 | 132 | 16 | 52 | 1836 | 571 | 52 | 12.58 | 114.75 | |
| 17 | Anti-Infective Agents | journal | 0.364 Q3 | 26 | 25 | 77 | 2808 | 83 | 74 | 1.20 | 112.32 | |
| 18 | Current Neuropharmacology | journal | 1.038 Q2 | 103 | 35 | 81 | 3841 | 197 | 79 | 2.09 | 109.74 | |
| 19 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.192 Q3 | 27 | 36 | 113 | 3866 | 39 | 101 | 0.23 | 107.39 | |
| 20 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.628 Q2 | 43 | 30 | 99 | 3163 | 210 | 98 | 2.14 | 105.43 | |
| 21 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.424 Q1 | 108 | 93 | 182 | 9648 | 833 | 167 | 4.33 | 103.74 | |
| 22 | Expert Opinion on Therapeutic Targets | journal | 1.469 Q1 | 106 | 116 | 345 | 11796 | 1225 | 321 | 3.82 | 101.69 | |
| 23 | Infectious Disorders - Drug Targets | journal | 1.170 Q1 | 61 | 53 | 96 | 5332 | 289 | 86 | 2.78 | 100.60 | |
| 24 | Mini-Reviews in Medicinal Chemistry | journal | 0.984 Q2 | 107 | 149 | 394 | 14757 | 1314 | 391 | 3.26 | 99.04 | |
| 25 | Cellular and Molecular Life Sciences | journal | 3.995 Q1 | 261 | 299 | 843 | 28820 | 5655 | 839 | 6.45 | 96.39 |  |
| 26 | Current Drug Targets | journal | 1.775 Q1 | 119 | 131 | 427 | 12582 | 1765 | 379 | 3.86 | 96.05 | |
| 27 | CNS and Neurological Disorders - Drug Targets | journal | 1.772 Q1 | 96 | 52 | 150 | 4787 | 614 | 134 | 3.85 | 92.06 | |
| 28 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.951 Q2 | 100 | 125 | 259 | 11138 | 976 | 253 | 3.57 | 89.10 | |
| 29 | Issues in Toxicology | book series | 0.197 Q3 | 18 | 18 | 51 | 1596 | 15 | 47 | 0.29 | 88.67 | |
| 30 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.184 Q3 | 17 | 27 | 125 | 2388 | 47 | 112 | 0.37 | 88.44 | |
| 31 | Neurotherapeutics | journal | 2.326 Q1 | 136 | 75 | 198 | 6608 | 1175 | 183 | 6.28 | 88.11 | |
| 32 | Expert Opinion on Therapeutic Patents | journal | 0.477 Q3 | 88 | 109 | 332 | 9508 | 405 | 321 | 1.21 | 87.23 | |
| 33 | Current Pharmacogenomics and Personalized Medicine | journal | 0.213 Q3 | 20 | 27 | 26 | 2321 | 16 | 26 | 0.62 | 85.96 | |
| 34 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.724 Q2 | 45 | 31 | 89 | 2650 | 210 | 88 | 2.28 | 85.48 | |
| 35 | Current Topics in Pharmacology | journal | 0.118 Q4 | 8 | 15 | 52 | 1247 | 7 | 52 | 0.15 | 83.13 |  |
| 36 | Expert Opinion on Biological Therapy | journal | 1.137 Q1 | 102 | 141 | 454 | 11591 | 1569 | 448 | 3.57 | 82.21 | |
| 37 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | |
| 38 | Inflammation and Allergy - Drug Targets | journal | 0.911 Q2 | 55 | 51 | 97 | 3969 | 285 | 92 | 3.02 | 77.82 | |
| 39 | Journal of International Peacekeeping | journal | 0.101 Q4 | 14 | 15 | 44 | 1145 | 8 | 42 | 0.15 | 76.33 | |
| 40 | Expert Opinion on Pharmacotherapy | journal | 0.613 Q2 | 93 | 271 | 794 | 20462 | 1915 | 773 | 2.52 | 75.51 | |
| 41 | Apoptosis : an international journal on programmed cell death | journal | 1.825 Q1 | 128 | 129 | 506 | 9689 | 2186 | 502 | 4.48 | 75.11 | |
| 42 | Pharmacognosy Reviews (discontinued) | journal | 68 | 41 | 0 | 3074 | 0 | 0 | 0.00 | 74.98 | | |
| 43 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.104 Q4 | 29 | 5 | 9 | 374 | 1 | 3 | 0.11 | 74.80 | |
| 44 | Expert Opinion on Investigational Drugs | journal | 1.251 Q1 | 117 | 165 | 481 | 12080 | 1956 | 449 | 4.54 | 73.21 | |
| 45 | Current Opinion in Investigational Drugs | journal | 1.276 Q1 | 83 | 136 | 371 | 9871 | 1308 | 339 | 3.66 | 72.58 | |
| 46 | Infection and Drug Resistance | journal | 65 | 6 | 0 | 435 | 0 | 0 | 0.00 | 72.50 |  | |
| 47 | Expert Review of Vaccines | journal | 1.278 Q1 | 105 | 156 | 310 | 11295 | 1142 | 276 | 3.97 | 72.40 | |
| 48 | Future Medicinal Chemistry | journal | 90 | 120 | 0 | 8645 | 0 | 0 | 0.00 | 72.04 | | |
| 49 | Perspectives in Medicinal Chemistry | journal | 0.103 Q4 | 17 | 3 | 7 | 212 | 0 | 7 | 0.00 | 70.67 | |
| 50 | Clinical Pharmacokinetics | journal | 1.494 Q1 | 184 | 60 | 212 | 4237 | 1153 | 202 | 5.36 | 70.62 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data